Medical network - July 3 recently, the ministry of commerce issued the medicine circulation industry in 2016 to run statistical analysis report, 100, 2016 years ago now pharmaceutical wholesale enterprises advocate business wu income total of 1 trillion yuan, up 14.0% from a year earlier. It accounted for 70.9% of the country's total pharmaceutical market over the same period. Among them, the top three total more than 500 billion yuan, the state pharmaceutical group is close to 300 billion yuan, China resources medicine, Shanghai medicine exceed 100 billion yuan.
The overall size has been increasing year by year, and the growth rate has picked up slightly
The sales trend of drug circulation industry in recent years
In 2016, the sales volume of drug circulation market steadily increased, and the growth rate recovered slightly. The total sales volume of the seven categories of pharmaceutical products nationwide totaled 18,393 billion yuan, with a year-on-year growth of 10.4%, up 0.2 percentage points from the previous year.
The report analyzed that the sales growth of drug wholesalers in 2016 slowed down, but concentration increased slightly. Sales of pharmaceutical retail enterprises have recovered and the chain rate continues to improve; Pharmaceutical e-commerce is an important development model in the pharmaceutical circulation industry; The operation efficiency and service function of medical logistics are continuously improved.
Margins picked up a bit
The profits of pharmaceutical circulation in recent years (unit: billion yuan)
In 2016, the total amount of profits of drug circulation in China was 32.2 billion yuan, excluding non-specific factors, which were up by 10.9% year on year, up by 0.3 percentage point year-on-year. Average gross margin is 7.0%, up 0.1 percentage point year on year; The average fee rate was 5.2%, down 0.2 percentage points year on year; Average profit margin was 1.8%, up 0.1 percentage point year on year; Net profit margin of 1.5%, up 0.1 percentage point year on year.
Pharmaceutical sales dominate
2016 full industry sales category structure
According to the sales category classification, western medicine dominates sales, sales account for 74.4% of the total amount of seven class of pharmaceutical sales, followed by proprietary Chinese medicine class (15.0%), traditional Chinese medicine class accounted for 3.0%, medical equipment class (3.3%), chemical reagent class (1.2%), glassware class accounted for 0.1%, other classes (3.0%).
The top 100 companies are up
The proportion of the top 100 enterprises in wholesale
In terms of market share, the concentration of drug wholesale industry is further improved. In 2016, the total business income of 100 drug wholesalers had exceeded RMB 100 billion, up 13.97% year on year, accounting for 70.9% of the total pharmaceutical market in the same period, up 2.0% year on year.
With the implementation of various medical reform policies, the consolidation of drug wholesale industry has been further accelerated. In the market has a certain scale of pharmaceutical wholesale enterprises are actively layout, efforts to improve its management ability, operation ability and management ability, target stride forward to the network, intensive and informationization, promote the construction of modern medicine circulation system.
2016 wholesale enterprise TOP10 (unit: 10,000 yuan)
From the main business income of wholesale enterprises, the top three total more than 500 billion yuan, of which the national pharmaceutical group is close to 300 billion yuan, and China resources medicine and Shanghai medicine exceed 100 billion yuan. In terms of growth rate, the top 100 business income of wholesale enterprises increased by 14.0% year-on-year, and the growth rate decreased by 1.6%. The growth rate of large-scale drug wholesalers is higher than the industry average, but it has slowed down, and the leading enterprises have developed rapidly and the industry concentration has been continuously improved.
For development trend, according to the report, 2017 is the deepening medical and health system reform and advance the supply side key of structural reform, the general office of the state council on further reform and improve the pharmaceutical production circulation use policy several opinions, the printing on drug procurement in the public medical institutions in the implementation of the implementation of the "two votes" opinion (trial) notice, under the guidance of guiding policy documents such as the reform measures will comprehensively implement, industry development is facing new opportunities and challenges.
The main business income of wholesale enterprises in 2016 is TOP100 (unit: ten thousand yuan)
Source: ministry of commerce's report on operation statistical analysis of drug circulation industry in 2016
|
